Cameron Brink achieves visual freedom with the EVO implantable lenses

Basketball Player

Cam Brink 80 41

Vision struggles on and off the court

Cameron Brink, a star on the women’s basketball team of Stanford University, faced the daily struggles of glasses and contacts, impacting both her personal and professional life.

Cameron Brink High Res v2

EVO ICL: the game-changer

Cameron's vision problems started in the 5th grade when glasses became a part of her daily life. Later, her reliance on visual aids expanded to contacts, introducing a new set of challenges. For approximately 12 years, Cameron navigated the world through glasses and contacts. "I've been wearing glasses or contacts since I was in the 5th grade. And started to struggle with eye dryness and irritation. As a basketball player, I was constantly losing my contacts during games and practice!" The burden of being nearsighted became an accepted norm… until Cameron learned about the EVO Implantable Collamer® Lenses (EVO ICL).
Cameron's decision to correct her nearsightedness with the EVO ICL procedure was fueled by the desire to break free from the constraints of traditional vision correction methods. With EVO ICL, Cameron's life took a remarkable positive turn. "My life has changed for the better! I don't have to fumble with contacts anymore when I wake up or during the day, and my eyes aren't irritated anymore. Plus, I don't have to worry about losing lenses on the court!"
The differences post-EVO ICL are noticeable. In Cameron's words, "my eyes aren't irritated and dry like they were when I wore contacts. And I love waking up in the morning seeing clearly." Cameron emphasizes the life-changing benefits that extend beyond the basketball court. Choosing EVO ICL was not just about vision correction; it was a lifestyle choice. "The time I save each day! Living a life free of contacts was a huge selling point; as well as the fact that the EVO lens implant is reversible if I ever need it."
Cam Brink1
Cam Brink5
Cam Brink6

Join her in experiencing the world with newfound clarity and confidence. For those on the fence about EVO ICL, Cameron passionately encourages,

"Talk to your eye doctor today. It's truly a life-changing procedure!"

Ready to embrace a life without the hassle of glasses and contacts? Discover the possibilities with EVO ICL. Call an EVO advisor today to schedule an appointment with an eye doctor near you, and embark on your own journey towards visual freedom!

Prêt à découvrir la liberté visuelle grâce à EVO ICL? Trouver un médecin aujourd’hui

Informations importantes sur la sécurité

The EVO/EVO+ ICLs are indicated for patients who are 21 to 60 years of age and are available in spherical powers ranging from -3.0 D to -18.0 D for the correction/reduction of myopia with or without a cylinder power range from 1.0 D to 6.0 D. The hyperopic ICLs are indicated for patients who are 21 to 45 years of age and are available in powers ranging from +3.0 D to +10.0 D for the correction/reduction of hyperopia. In order to be sure that your surgeon will use an ICL with the most adequate power for your eye, your nearsightedness, farsightedness and astigmatism should be stable for at least a year before undergoing eye surgery. ICL surgery may improve your vision without eyeglasses or contact lenses. ICL surgery does not eliminate the need for reading glasses, even if you have never worn them before. ICL represents an alternative to other refractive surgeries including, laser assisted in situ keratomileusis (LASIK), photorefractive keratectomy (PRK), incisional surgeries, or other means to correct your vision such as contact lenses and eye glasses. Implantation of an ICL is a surgical procedure, and as such, carries potentially serious risks. The following represent potential complications/ adverse reactions reported in conjunction with refractive surgery in general: additional surgeries, cataract formation, loss of best corrected vision, raised pressure inside the eye, loss of cells on the innermost surface of the cornea, conjunctiva I irritation, acute corneal swelling, persistent corneal swelling, endophthalmitis (total eye infection), significant glare and/or halos around lights, hyphaema (blood in the eye), hypopyon (pus in the eye), eye infection, ICL dislocation, macular oedema, non-reactive pupil, pupillary block glaucoma, severe inflammation of the eye, iritis, uveitis, vitreous loss and corneal transplant. Before considering ICL surgery you should have a complete eye examination and talk with your eye care professional about ICL surgery, especially the potential benefits, risks, and complications. You should discuss the time needed for healing after surgery.

Références

Références

1. Patient Survey, STAAR Surgical ICL Data Registry, 2018

2. Sanders D. Vukich JA. Comparison of implantable collamer lens (ICL) and laser-assisted in situ keratomileusis (LASIK) for Low Myopia. Cornea. 2006 Dec; 25(10):1139-46. Patient Survey, STAAR Surgical ICL Data Registry, 2018

3. Naves, J.S. Carracedo, G. Cacho-Babillo, I. Diadenosine Nucleotid Measurements as Dry-Eye Score in Patients After LASIK and ICL Surgery. Presented at American Society of Cataract and Refractive Surgery (ASCRS) 2012.

4. Shoja, MR. Besharati, MR. Dry eye after LASIK for myopia: Incidence and risk factors. European Journal of Ophthalmology. 2007; 17(1): pp. 1-6.

5a. Lee, Jae Bum et al. Comparison of tear secretion and tear film instability after photorefractive keratectomy and laser in situ keratomileusis. Journal of Cataract & Refractive Surgery , Volume 26 , Issue 9 , 1326 - 1331.

5b. Parkhurst, G. Psolka, M. Kezirian, G. Phakic intraocular lens implantantion in United States military warfighters: A retrospective analysis of early clinical outcomes of the Visian ICL. J Refract Surg. 2011;27(7):473-481.

*American Refractive Surgery Council